Ingredients & Formulation
King Faisal Specialist Hospital Showcases Applied AI Ecosystem in Radiology at HLTH Europe 2026
Professor Ahmad AbuSalah, PhD, Director of the Digital Innovation Hub at King Faisal Specialist Hospital & Research Cen…
All 674 stories
Ingredients & Formulation
Aplagon Announces EUR 5 Million Financing to Broaden Phase 2 Trials of its APAC Therapy in Thrombo-Inflammatory Diseases
Aplagon Announces EUR 5 Million Financing to Broaden Phase 2 Trials of its APAC Therapy in Thrombo-Inflammatory Diseases
Ingredients & Formulation
Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement
REYKJAVIK, ICELAND (June 16, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechn…
Condition-Specific Health
Lifeway Kefir Marks 40 Years with SoHo Pop-Up on National Kefir Day
The Nasdaq-listed kefir pioneer uses experiential retail to drive category awareness as fermented dairy's probiotic cre…
Ingredients & Formulation
Dignitas Wins NAIC: The ROOT Brands Powers Pokémon UNITE Victory
How Dignitas Pokémon UNITE utilized advanced cognitive support to dominate the NAIC and redefine wellness in esports.
Ingredients & Formulation
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differen…
Ingredients & Formulation
Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026
-- Setmelanotide therapy achieved robust, sustained and clinically significant weight loss in patients with acquired HO…
Ingredients & Formulation
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
REYKJAVIK, ICELAND (June 15, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechn…
Ingredients & Formulation
ETHY-001 Shows Complete TSHR Blockade in Graves' Disease Preclinical Data
Early mechanistic data positions ETHY-001 as a differentiated candidate in thyroid-eye disease, a space drawing growing…
Industry & Business
Editor's Note: Submitted Release Outside Functional News Coverage Scope
Functional News covers ingredients, formulations, clinical evidence, and market trends in functional foods and nutraceu…
Condition-Specific Health
Peanuts Linked to Brain Health Benefits via Nutrient Density
As the cognitive-wellness category accelerates, operators are eyeing whole-food ingredients with established safety pro…
Condition-Specific Health
Rivox Labs Debuts Nicotine-Free Focus Pouches and Energy Gum
The nicotine-free oral delivery format is gaining traction as a disruptive vector for nootropic and energy ingredients …